BORIANI, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 94.732
EU - Europa 34.240
AS - Asia 32.847
SA - Sud America 6.923
AF - Africa 598
OC - Oceania 354
Continente sconosciuto - Info sul continente non disponibili 62
Totale 169.756
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 93.553
GB - Regno Unito 10.823
SG - Singapore 10.632
CN - Cina 9.948
BR - Brasile 5.964
HK - Hong Kong 5.864
IT - Italia 5.439
DE - Germania 3.126
PL - Polonia 3.103
SE - Svezia 2.737
FI - Finlandia 2.375
TR - Turchia 2.018
UA - Ucraina 1.839
RU - Federazione Russa 1.631
VN - Vietnam 1.127
BG - Bulgaria 869
KR - Corea 713
FR - Francia 663
ID - Indonesia 522
BZ - Belize 402
NL - Olanda 390
CA - Canada 342
AR - Argentina 340
AU - Australia 334
IN - India 327
JP - Giappone 293
MX - Messico 255
IE - Irlanda 233
AT - Austria 229
BD - Bangladesh 228
IQ - Iraq 205
ES - Italia 197
ZA - Sudafrica 163
EC - Ecuador 135
CO - Colombia 121
PK - Pakistan 116
MA - Marocco 111
UZ - Uzbekistan 105
VE - Venezuela 105
LT - Lituania 102
BE - Belgio 79
CL - Cile 71
MY - Malesia 64
JO - Giordania 62
KE - Kenya 59
EG - Egitto 57
RO - Romania 57
PY - Paraguay 56
AE - Emirati Arabi Uniti 55
TN - Tunisia 54
AZ - Azerbaigian 53
IL - Israele 53
CH - Svizzera 52
SA - Arabia Saudita 48
NP - Nepal 47
IR - Iran 44
PE - Perù 44
UY - Uruguay 43
BO - Bolivia 42
GE - Georgia 40
DZ - Algeria 38
GR - Grecia 38
EU - Europa 36
JM - Giamaica 36
KZ - Kazakistan 35
TW - Taiwan 35
CZ - Repubblica Ceca 31
PH - Filippine 31
RS - Serbia 31
DO - Repubblica Dominicana 28
PT - Portogallo 23
TH - Thailandia 23
HU - Ungheria 22
SN - Senegal 22
AL - Albania 21
KG - Kirghizistan 21
PA - Panama 21
BY - Bielorussia 20
OM - Oman 20
DK - Danimarca 19
LB - Libano 18
CR - Costa Rica 17
NZ - Nuova Zelanda 16
PS - Palestinian Territory 15
TT - Trinidad e Tobago 15
NO - Norvegia 14
CU - Cuba 13
SK - Slovacchia (Repubblica Slovacca) 13
AM - Armenia 12
ET - Etiopia 12
NI - Nicaragua 12
GT - Guatemala 11
BH - Bahrain 10
HN - Honduras 10
MD - Moldavia 10
NG - Nigeria 10
QA - Qatar 10
XK - ???statistics.table.value.countryCode.XK??? 10
A2 - ???statistics.table.value.countryCode.A2??? 9
BA - Bosnia-Erzegovina 9
Totale 169.556
Salva come PNG Salva come JPEG
Città #
Fairfield 12.853
Woodbridge 7.524
Ashburn 7.374
Southend 7.258
Santa Clara 7.131
Singapore 7.003
Houston 5.899
Hong Kong 5.803
Seattle 4.990
Cambridge 4.155
Wilmington 4.146
Chandler 4.145
Jacksonville 3.664
Hefei 3.257
Warsaw 2.981
Ann Arbor 2.815
London 2.562
Dearborn 2.335
Helsinki 2.063
San Jose 2.042
Beijing 1.794
Modena 1.493
Nyköping 1.463
New York 1.432
San Diego 1.253
Izmir 1.221
Chicago 1.080
The Dalles 1.075
Los Angeles 1.004
Princeton 893
Sofia 861
Eugene 729
Seoul 695
Dallas 677
Moscow 522
Buffalo 518
São Paulo 479
Jakarta 459
Shanghai 432
Council Bluffs 418
Belize City 400
Columbus 398
Ho Chi Minh City 383
Milan 382
Salt Lake City 336
Munich 269
Bologna 266
Rome 261
Falls Church 257
Hanoi 255
Boardman 231
Atlanta 227
Dublin 209
Rio de Janeiro 200
Nuremberg 197
Redondo Beach 190
Fremont 188
Tokyo 188
Saint Louis 169
Perth 168
Las Vegas 165
Norwalk 163
Guangzhou 160
Amsterdam 154
Kent 150
Belo Horizonte 143
Albuquerque 139
Tampa 138
Elk Grove Village 134
Kunming 132
Lappeenranta 126
Redwood City 120
Nanjing 117
Brooklyn 112
Frankfurt am Main 110
Toronto 110
Brasília 101
Kilburn 100
Johannesburg 98
Curitiba 97
Phoenix 95
Tashkent 94
Vienna 88
Philadelphia 84
Naples 83
Jinan 81
Baghdad 78
Mexico City 76
Florence 75
Grafing 75
Porto Alegre 75
Stockholm 74
San Francisco 73
Sterling 72
Miami 69
Sydney 66
Buenos Aires 64
Turku 64
Montreal 63
Campinas 62
Totale 127.752
Salva come PNG Salva come JPEG
Nome #
Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation 649
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy 620
'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: The EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry 619
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing 610
'Real-world' atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase 596
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) 555
2018 EHRA expert consensus statement on lead extraction: Recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: Endorsed by APHRS/HRS/LAHRS 553
A changing scenario in the clinical use of implantable defibrillators: the need for long-term data on lead performance. 525
La sindrome da pacemaker. 486
Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC (Eur Heart J (2021) 42 (373–498) DOI: 10.1093/eurheartj/ehaa612) 449
Atrial Fibrillation in the Setting of Acute Pneumonia: Not a Secondary Arrhythmia 444
Linee guida AIAC all'impianto di pacemaker, dispositivi per la resincronizzazione cardiaca, defibrillatori automatici e loop recorder. Update 2011. 431
Screening for atrial fibrillation: A Report of the AF-SCREEN International Collaboration 430
A prospective randomized evaluation of VV delay optimization in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques 420
Registro Italiano Pacemaker e Defibrillatori: Bollettino Periodico 2016 Associazione Italiana di Aritmologia e Cardiostimolazione 372
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation 359
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) 345
The future of continuing medical education: the roles of medical professional societies and the health care industry: Position paper prepared with contributions from the European Society of Cardiology Committees for Advocacy, Education and Industry Relations, Endorsed by the Board of the European Society of Cardiology 323
Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial 319
Acute hemodynamic effects of intravenous adenosine in patients with associated pulmonary arterial hypertension: Comparison with intravenous epoprostenol 319
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA) 317
Guía de práctica clínica de la ESC 2013 sobre estimulación cardiaca y terapia de resincronización cardiaca 316
Prevalence and clinical significance of left bundle branch block according to classical or strict definition criteria in permanent pacemaker patients 305
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) 305
P wave dispersion and short-term vs. late atrial fibrillation recurrences after cardioversion 297
Home care for heart failure: can caregiver education prevent hospital admissions? A randomized trial in primary care 291
QRS pattern and improvement in right and left ventricular function after cardiac resynchronization therapy: a radionuclide study 289
Atrial fibrillation in patients with active malignancy and use of anticoagulants: Under-prescription but no adverse impact on all-cause mortality 287
Clinically guided pacemaker choice and setting: pacemaker expert programming study 285
Cardiac involvement in systemic sclerosis: identification of high-risk patient profiles in different patterns of clinical presentation 285
108th ENMC International Workshop, 3rd Workshop of the MYO-CLUSTER project: EUROMEN, 7th International Emery-Dreifuss Muscular Dystrophy (EDMD) Workshop, 13-15 September 2002, Naarden, The Netherlands. 282
Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report 282
12-year Temporal Trend in Referral Pattern and Test Results of Stress Echocardiography in a Tertiary Care Referral Center with Moderate Volume Activities and Cath-lab Facility 279
Role of the tricuspid regurgitation after mitraclip and transcatheter aortic valve implantation: a systematic review and meta-analysis 276
Impact of COVID-19 pandemic on the clinical activities related to arrhythmias and electrophysiology in Italy: results of a survey promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing) 275
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) With the special contribution of the European Heart Rhythm Association (EHRA) 275
Radar-Based Monitoring of Vital Signs: A Tutorial Overview 274
Meta-analysis of clinical outcomes of electrical cardioversion and catheter ablation in patients with atrial fibrillation and chronic kidney disease 271
Cardiolaminopathies from bench to bedside: challenges in clinical decision-making with focus on arrhythmia-related outcomes 271
Implantable cardioverter-defibrillator–computed respiratory disturbance index accurately identifies severe sleep apnea: The DASAP-HF study 271
Chronic kidney disease and arrhythmias: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference 271
Cardiac device therapy in patients with left ventricular dysfunction and heart failure: ‘real-world’ data on long-term outcomes (mortality, hospitalizations, days alive and out of hospital) 269
Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report from the EURObservational research programme pilot survey on atrial fibrillation 267
The increased risk of stroke/transient ischemic attack in women with a cardiac implantable electronic device is not associated with a higher atrial fibrillation burden 265
The 2018 European Heart Rhythm Association Practical Guide on the use of non-Vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: Executive summary 263
Electrocardiogram Alterations Associated With Psychotropic Drug Use and CACNA1C Gene Variants in Three Independent Samples 262
Practical management of ibrutinib in the real life: Focus on atrial fibrillation and bleeding 261
Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. 260
Rate vs. rhythm control and adverse outcomes among European patients with atrial fibrillation 260
New classification of geometric patterns considering left ventricular volume in patients with chronic aortic valve regurgitation: Prevalence and association with adverse cardiovascular outcomes 260
Heart failure after myocardial revascularization: Risk markers 259
Health care cost analysis of enhanced pacing modalities in bradycardia patients: Portuguese case study on the results of the MINERVA trial 256
The wearable cardioverter-defibrillator: Current technology and evolving indications 256
Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry 255
The QRS interval in patients treated with resynchronization therapy: which value? 254
Management of cardiopulmonary disease in patients with systemic sclerosis: cardiorheumatology clinic and patient care standardization proposal 254
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy 253
Cause of death and predictors of all-cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: Data from ROCKET AF 252
Detection of new atrial fibrillation in patients with cardiac implanted electronic devices and factors associated with transition to higher device-detected atrial fibrillation burden 252
Overweight and obesity in patients with atrial fibrillation: Sex differences in 1-year outcomes in the EORP-AF General Pilot Registry 252
Health economics and the European Heart Rhythm Association. 251
Emery-Dreifuss Muscular Dystrophy-Associated Mutant Forms of Lamin A Recruit the Stress Responsive Protein Ankrd2 into the Nucleus, Affecting the Cellular Response to Oxidative Stress 250
Letter by Gasparini and Boriani Regarding Article, "Cardiac Resynchronization Therapy in Patients With Permanent Atrial Fibrillation: Results From the Resynchronization for Ambulatory Heart Failure Trial (RAFT)" 249
11C-mHED for PET / CT: principles of synthesis, methodology and first clinical applications 249
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: A joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE) 248
QRS interval time-related changes and prognosis in heart failure 245
Combined use of morphology discrimination, sudden onset, and stability as discriminating algorithms in single chamber cardioverter defibrillators 245
Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry 245
Inappropriate shock for myopotential over-sensing in a patient with subcutaneous ICD 244
Elevated TGF β2 serum levels in Emery-Dreifuss Muscular Dystrophy: Implications for myocyte and tenocyte differentiation and fibrogenic processes 244
'Pill-in-the-pocket' treatment for recent-onset atrial fibrillation [4] 244
Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy 243
Prediction of cardiac resynchronization therapy response: value of calibrated integrated backscatter imaging. 243
Beta-blocker treatment guided by head-up tilt test in neurally mediated syncope 243
EACVI/EHRA Expert Consensus Document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation 243
'Real-World' antithrombotic treatment in atrial fibrillation: The eorp-af pilot survey 242
Cardiac resynchronization and implantable cardioverter defibrillator therapy: Preliminary results from the InSync Implantable Cardioverter Defibrillator Italian Registry 242
Regional differences in presentation and treatment of patients with atrial fibrillation in Europe: A report from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry 242
Atrioventricular junction ablation in patients with atrial fibrillation treated with cardiac resynchronization therapy: positive impact on ventricular arrhythmias, implantable cardioverter-defibrillator therapies and hospitalizations 242
Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis 242
Biventricular vs. left univentricular pacing in heart failure: Rationale, design, and endpoints of the B-LEFT HF study 241
Management of Phrenic Stimulation in CRT Patients over the Long Term: Still an Unmet Need ? 241
Implantable dual-chamber defibrillator for the selective treatment of spontaneous atrial and ventricular arrhythmias: arrhythmia incidence and device performance. 241
Far-field R wave oversensing in dual-chamber pacemakers designed for atrial arrhythmia management: effect of pacing site and lead tip to ring distance 240
The MOnitoring Resynchronization dEvices and CARdiac patiEnts (MORE-CARE) Randomized Controlled Trial: Phase 1 Results on Dynamics of Early Intervention With Remote Monitoring 239
Randomized comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from sinus node disease and atrial fibrillation and implanted with a DDDRP device 239
Battery longevity of implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators: technical, clinical and economic aspects. An expert review paper from EHRA 239
Atrial fibrillation in dilated cardiomyopathy: Outcome prediction from an observational registry 239
Implant rates of cardiac implantable electrical devices in Europe: A systematic literature review 238
European Society of Cardiology-Proposed Diagnostic Echocardiographic Algorithm in Elective Patients with Clinical Suspicion of Infective Endocarditis: Diagnostic Yield and Prognostic Implications in Clinical Practice 238
Asymptomatic lone atrial fibrillation - how can we detect the arrhythmia? 237
Role of ventricular Autocapture function in increasing longevity of DDDR pacemakers: a prospective study. 237
Clinical and electrocardiographic characteristics at admission of COVID-19/SARS-CoV2 pneumonia infection 237
Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy 236
Switching among Equivalents in Chronic Cardiovascular Therapies: 'Real World' Data from Italy 236
New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial 235
Atrial evoked response integral for automatic capture verification in atrial pacing 234
Risk stratification of cardiovascular and heart failure hospitalizations using integrated device diagnostics in patients with a cardiac resynchronization therapy defibrillator 234
European Society of Cardiology: the 2023 Atlas of Cardiovascular Disease Statistics 233
Cardiac resynchronization therapy: effects on left and right ventricular ejection fraction during exercise. 233
Totale 29.981
Salva come PNG Salva come JPEG
Categoria #
all - tutte 737.405
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 737.405
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111.166 0 0 0 0 0 0 2.848 2.882 1.051 2.005 1.309 1.071
2021/202215.465 664 1.848 1.677 712 427 1.286 887 786 1.655 1.369 2.411 1.743
2022/202311.536 1.660 974 714 826 1.469 1.536 259 1.187 1.758 206 597 350
2023/20249.853 393 632 435 803 2.283 1.440 447 1.696 223 253 327 921
2024/202533.713 1.151 386 730 1.788 4.911 5.146 3.766 2.148 4.150 2.542 3.045 3.950
2025/202632.633 3.554 1.887 5.259 4.816 5.394 9.125 2.598 0 0 0 0 0
Totale 172.924